PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Rabin Medical Center, Petah Tikva, Israel; Neuroimmunology Unit, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Israel. Electronic address: lotan.itay1@gmail.com.\', \'Department of Neurology, Rabin Medical Center, Petah Tikva, Israel; Neuroimmunology Unit, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Israel.\', \'Sackler Faculty of Medicine, Tel-Aviv University, Israel; Department of Ophthalmology and Neuro-Ophthalmology Unit, Rabin Medical Center, Petah Tikva, Israel.\', \'Department of Neurology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0960-8966(22)00030-X10.1016/j.nmd.2022.01.013
?:doi
?:hasPublicationType
?:journal
  • Neuromuscular disorders : NMD
is ?:pmid of
?:pmid
?:pmid
  • 35227552
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35227552>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35227552>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all